FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

7 results

dasatinib
(Dasatinib)
Dr. Reddy's Laboratories Inc.
Usage: Dasatinib tablets are indicated for adults with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and those with advanced Ph+ CML or Ph+ acute lymphoblastic leukemia (ALL) who are resistant or intolerant to prior therapy. They are also approved for pediatric patients with Ph+ CML and newly diagnosed Ph+ ALL.
dasatinib
(dasatinib)
Biocon Pharma Inc.
Usage: Dasatinib is indicated for treating adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in chronic phase, Ph+ CML with resistance to prior therapy, and Ph+ acute lymphoblastic leukemia (ALL). It is also indicated for pediatric patients aged 1 and older with Ph+ CML and newly diagnosed Ph+ ALL.
dasatinib
(dasatinib)
Prasco Laboratories
Usage: Dasatinib tablets are indicated for adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML), Ph+ CML with resistance/intolerance to prior therapy, and Ph+ acute lymphoblastic leukemia (ALL). They are also indicated for pediatric patients (≥1 year) with Ph+ CML and newly diagnosed Ph+ ALL with chemotherapy.
doxorubicin hydrochloride
(DOXORUBICIN HYDROCHLORIDE)
Fresenius Kabi USA, LLC
Usage: Doxorubicin Hydrochloride Injection is indicated for treating various cancers, including leukemias, Wilms' tumor, neuroblastoma, sarcomas, and several carcinomas. It is also used as adjuvant therapy for women with axillary lymph node involvement post-primary breast cancer resection.
nelarabine
(Nelarabine)
XGen Pharmaceuticals DJB, Inc.
Usage: Nelarabine injection is indicated for treating T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adults and children aged 1 year and older, specifically when the disease has not responded to or has relapsed after at least two chemotherapy regimens.
nelarabine
(Nelarabine)
Zydus Pharmaceuticals USA Inc.
Usage: Nelarabine Injection is indicated for treating T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in adults and pediatric patients aged 1 year and older who have not responded to or have relapsed after at least two chemotherapy regimens.
nelarabine
(Nelarabine)
Gland Pharma Limited
Usage: Nelarabine is indicated for treating T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in patients aged 1 year and older, specifically when the disease has not responded to or has relapsed after at least two chemotherapy regimens.

Medications for Precursor Tcell Lymphoblastic Leukemialymphoma

dasatinib

dasatinib

dasatinib

doxorubicin hydrochloride

nelarabine

nelarabine

nelarabine